Gemcitabine º´ÇÕÄ¡·á ÈÄ ¼Ò½ÇµÈ ºñ¼Ò¼¼Æ÷Æó¾Ï º´¹ß ½ÅÁõÈıº 1¿¹
Nephrotic Syndrome Disappeared after Gemcitabine Combination Therapy in a Patient with Progressive Non-small Cell Lung Cancer

´ëÇѽÅÀåÇÐȸÁö 2010³â 29±Ç 5È£ p.634 ~ p.637

ÀÌÀºÁ¤(Lee Eun-Jung) - °æÈñ´ëÇб³ µ¿¼­½ÅÀÇÇк´¿ø Á¾¾çÇ÷¾×³»°ú
ÀÌÀçÁø(Lee Jae-Jin) - °æÈñ´ëÇб³ µ¿¼­½ÅÀÇÇк´¿ø Á¾¾çÇ÷¾×³»°ú
¹®ÁÖ¿µ(Moon Ju-Young) - °æÈñ´ëÇб³ µ¿¼­½ÅÀÇÇк´¿ø ½ÅÀå³»°ú
À¯ÁöÈ«(Yoo Jee-Hong) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿¼­½ÅÀÇÇк´¿ø È£Èí±â³»°úÇб³½Ç
ÃÖõ¿õ(Choi Cheon-Woong) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿¼­½ÅÀÇÇк´¿ø È£Èí±â³»°ú
±èÀÌÇü(Kim Yee-Hyung) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ µ¿¼­½ÅÀÇÇк´¿ø È£Èí±â³»°ú
±è±³¿µ(Kim Gou-Young) - °æÈñ´ëÇб³ µ¿¼­½ÅÀÇÇк´¿ø º´¸®ÇаúÇб³½Ç

Abstract

Nephrotic syndrome has been reported to accompany a malignancy. Since the first case of the nephritic syndrome associated with extra-renal malignancy was reported in 1922, only a few cases of nephrotic syndrome accompanying other malignancies have been reported. Previous reports on such cases indicated a pattern of improvement in nephropathy as malignancy improved. But the cases of resolved nephropathy with aggravated cancer have scarcely been documented. Here we report a case of a 69 year-old male with nephrotic syndrome accompanying non-small cell lung cancer, whose proteinuria was normalized after chemotherapy while his cancer was aggravated.

Å°¿öµå

Nephrotic syndrome, Non-small cell lung carcinoma, Chemotherapy, Gemcitabine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
proteinuria was normalized after chemotherapy while his cancer was aggravated.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå